Conflicts of Interest

Research Funding to Institution:

AVEO, Arcus, Merck, Dragonfly Therapeutics, HiberCell, Incyte, Stata Oncology, ADC Therapeutics, Dracen Pharmaceuticals, Janssen, Adela, Astra-Zeneca, Pionyr, Tempus, VasGene Therapeutics, Gilead, POINT Biopharma, BMS, Pfizer, Daiichi Sankyo, Genentech, Arrowhead Pharmaceuticals, Exelixis, Surface Oncology

Consulting:

BMS, Pfizer, GNE/Roche, Aveo, Synthorx, Merck, Corvus, Surface Oncology, Aravive, Alkermes, Arrowhead, Eisai, Nikang Therapeutics, EUSA, Athenex, Debiopharm, HiberCell, MashupMD

Stock:

PTC therapeutics

MSD, Merck-Serono, Pfizer, GSK, Novartis, Roche, AZ, BMS, Exelexis, Ipsen, Seagen, Astellas, Jansen, Eisai, Mashup, Genentech, Natera, FMI, Takeda.